Struthers Richard Scott

Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) ยท President & CEO

Struthers Richard Scott is listed in public filings as director, officer: President & CEO. This Struthers Richard Scott insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) (CRNX). Investors use Struthers Richard Scott's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX--1k sharesGrant / ExerciseMay 29, 2026Disclosure amount unavailable111.1k shares----
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX--80k sharesGrant / ExerciseMay 29, 2026Disclosure amount unavailable80k shares----
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX--216.8k sharesGrant / ExerciseMay 29, 2026Disclosure amount unavailable222.2k shares----

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX$15M413.6k sharesSellMar 16, 2026$489.7K13.2k shares$37.11--
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX$15M404.8k sharesSellMar 16, 2026$331.8K8.8k shares$37.77--
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX$10.0M228k sharesGrant / ExerciseFeb 23, 2026$10.0M228k shares$43.79--
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX--426.8k sharesGrant / ExerciseFeb 23, 2026Disclosure amount unavailable62k shares----
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX$4.0M259.1k sharesGrant / ExerciseDec 18, 2025$434.2K28.4k shares$15.29--
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX$016.3k sharesGrant / ExerciseDec 18, 2025$151.7K16.3k shares$9.28--
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX$4.8M106k sharesSellSep 26, 2025$180.0K4k shares$45.00--
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX--320k sharesGrant / ExerciseMay 14, 2025Disclosure amount unavailable90.4k shares----
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX$081.3k sharesGrant / ExerciseApr 2, 2025$155.2K81.3k shares$1.91--
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX$11M330k sharesSellMar 19, 2025$562.5K16.5k shares$34.17--
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX$11M329.1k sharesSellMar 19, 2025$30.5K875 shares$34.83--
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX$12M313k sharesGrant / ExerciseFeb 20, 2025$11.5M313k shares$36.86--
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX--346.5k sharesGrant / ExerciseFeb 20, 2025Disclosure amount unavailable89k shares----
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX$5.8M100k sharesSellDec 2, 2024$575.7K10k shares$57.57--